PRTG News and Press, Portage Biotech Inc. From 06/29/21

Westport, Connecticut--(Newsfile Corp. - June 29, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology company focused on the development of therapies targeting cancer treatment resistance, today announced that the Company has been added to...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. The S&P 500 closed the week at another record high, posting its best weekly performance since February, as investors bet that higher infl...

Gainers: Kaleido Biosciences (KLDO) +15%, Pieris Pharmaceuticals (PIRS) +14%, Arcus Biosciences (RCUS) +14%, Compugen (CGEN) +14%, Atossa Therapeutics (ATOS) +14%.Losers: Portage Biotech (PRTG) -23%, Rite Aid (RAD) -14%, 4D Mole...

Portage Biotech (PRTG) shares slide 28.5% premarket on pricing public offering of 1M ordinary shares at $23 per share.Underwriters' over-allotment is an additional 150K ordinary shares.Offering is expected to close on June 28, 2021. Proceeds will be used for the acceleration of its ...

PPAMPicture/E+ via Getty Images Earnings news is moving shares of some household names on Thursday morning in pre-market trading. Drug store chain Rite Aid (RAD) dropped following the release of its quarterly report, while strong earnings sparked gains in shares of consulting firm Accenture (...

Westport, Connecticut--(Newsfile Corp. - June 24, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology company focused on the development of therapies and treatments targeting cancer treatment resistance, today announced that it has priced i...

Portage Biotech PRTG -28% on stock offering.Daqo New Energy DQ -10% following a report that the U.S. is poised to bar some solar products made in China's Xinjiang region.Biogen BIIB -8% in sympathy with Lilly's Alzheimer’s therapy plan. Yesterday...

Clinical-stage immuno-oncology company, Portage Biotech (PRTG) commences an underwritten public offering of its ordinary shares. Underwriters 30-day option to purchase up to an additional 15% of the number of the ordinary shares Net proceeds to be deployed for the acceleration of it...

Westport, Connecticut--(Newsfile Corp. - June 23, 2021) - Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company") a clinical-stage immuno-oncology company focused on the development of therapies and treatments targeting cancer treatment resistance, today announced that it has commence...

Gainers: Idera Pharmaceuticals (IDRA) +22%, Beyond Air (XAIR) +14%, Clover Health Investments (CLOV) +14%, Adial Pharmaceuticals (ADIL) +13%, CollPlant Biotechnologies (CLGN) +10%.Losers: Mereo BioPharma (MREO) -9%, Portage Biotech (PRTG) -9%, ...